Dr. Benjamin Taylor
Overview
My experience as a fellowship-trained urologic oncologist has taught me that optimizing medical care is a combination of incorporating evidence-based practices with a strong multidisciplinary team. I have always had deep compassion for patients as well as a curiosity about the science behind disease diagnosis, treatment, and prevention. There is great potential to both cure and improve the quality of life for patients with urologic disease. My training with leaders in the field of open and robotic surgery, pharmacotherapy, and integrative treatments has given me a dynamic toolset to address all of a patient’s needs. I offer minimally invasive surgery for a wide variety of malignant and benign urologic conditions to help patients recover quickly and allow them to spend more time on things that matter to them.
Dr. Taylor is highly rated in 22 conditions, according to our data. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Nephrectomy, and Ureteroscopy.
His clinical research consists of co-authoring 25 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
261 James Street, Suite 2G, Morristown, NJ 07960
16 Eden Lane, Whippany, NJ 07981
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
HMH - John Theurer Cancer Center - Hackensack
Tatyana Feldman is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Feldman is highly rated in 41 conditions, according to our data. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Benjamin Taylor
How do I make an appointment with Dr. Benjamin Taylor?
You can book an appointment with Dr. Benjamin Taylor by calling their office at 973-539-0333. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Benjamin Taylor a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benjamin Taylor is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Benjamin Taylor specialize in?
While Dr. Benjamin Taylor is a Urology, they have specific expertise in Prostate Cancer, Muscle Invasive Bladder Cancer, and Familial Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Benjamin Taylor participate in research or clinical trials?
Yes. Dr. Benjamin Taylor has published 25 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Benjamin Taylor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Benjamin Taylor accept my insurance?
Dr. Benjamin Taylor accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 973-539-0333 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Taylor isDistinguished. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Taylor isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Taylor isDistinguished. Learn about Prostate Cancer.
- Advanced
- Bilateral HydronephrosisDr. Taylor isAdvanced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Taylor isAdvanced. Learn about Bladder Cancer.
- Bladder ReconstructionDr. Taylor isAdvanced. Learn about Bladder Reconstruction.
- BoilsDr. Taylor isAdvanced. Learn about Boils.
- CarbuncleDr. Taylor isAdvanced. Learn about Carbuncle.
- FolliculitisDr. Taylor isAdvanced. Learn about Folliculitis.
- Experienced
- Acute CystitisDr. Taylor isExperienced. Learn about Acute Cystitis.
- Bladder StonesDr. Taylor isExperienced. Learn about Bladder Stones.
- Chromophobe Renal Cell CarcinomaDr. Taylor isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Taylor isExperienced. Learn about Clear Cell Sarcoma.
- Congenital Mesoblastic NephromaDr. Taylor isExperienced. Learn about Congenital Mesoblastic Nephroma.
- CystectomyDr. Taylor isExperienced. Learn about Cystectomy.